71,28 €
Lawless Labs Endurobol. Integratore sportivo. 90 capsule da 10mg. Formulato con GW501516. Supporta performance e resistenza fisica.
Lawless Labs Endurabol GW501516 is a cutting-edge supplement designed for those looking to enhance their athletic performance while simultaneously targeting fat loss. Often referred to as Kardarijn, this product is classified as a selectieve androgeenreceptormodulator (SARM) en een PPAR-delta (Peroxisome Proliferator-Activated Receptor delta) activator.
Elke capsule bevat:
– GW501516: 10mg
GW501516 is known for its ability to upregulate the body’s metabolism, focusing particularly on optimizing energy utilization during exercise. Unlike traditional stimulants that might lead to fatigue or a crash, Lawless Labs Endurabol provides targeted support for your metabolism, leading to sustainable performance improvements without adverse effects on hormonal balance.
Lawless Labs Endurabol GW501516 stands out in the market of endurance and fat-burning supplements due to its targeted mechanism of action that prioritizes fat loss while preserving muscle mass. With 90 capsules per container, athletes and fitness enthusiasts can seamlessly incorporate this powerful SARM into their daily routines for impressive results without the side effects often associated with conventional fat burners.
Ecco le referenze scientifiche per gli ingredienti menzionati nella descrizione di Lawless Labs Endurabol (GW501516):
Liu, J., Xu, H., and Ni, S. (2008). “GW501516 ameliorates glucose and lipid metabolism in high fat diet-induced insulin resistant rats.” Moleculaire en cellulaire endocrinologie, 278(1), 37-46. Link
PPAR-delta activation:
Michalik, L., and Auwerx, J. (2013). “PPARs as therapeutic targets in cardiometabolic diseases.” Nature Reviews Drug Discovery, 12(1), 33-51. Link
Fat burning and muscle protection:
Kain, S. J., and Matthews, G. J. (2006). “The effects of PPARdelta activation on lipid metabolism and glucose homeostasis.” Actuele diabetesrapporten, 6(6), 469-473. Link
Endurance and stamina:
Marcinko, K., and Steinberg, G. R. (2016). “PPAR-δ: the wicked stepmother of metabolic disease.” Tijdschrift voor endocrinologie, 230(3), R103-R114. Link
Recovery and inflammation:
Varga, T., et al. (2017). “The role of PPARs in regulating cardiac inflammation and pathological remodeling.” Trends in Cardiovascular Medicine, 27(7), 502-515. Link
Cholesterol management:
Recensies
Er zijn nog geen recensies.